December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 08, 2026
According to market projections, the mental health tester market was valued at USD 1.78 billion in 2026 and is projected to reach USD 3.43 billion by 2035, expanding at a CAGR of 7.54% from 2026 to 2035. The mental health tester market report provides comprehensive insights into product type, application, end-user, and technology segments....
January 07, 2026
According to forecasts, the U.S. liquid biopsy market was valued at USD 2.44 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to USD 8.90 billion by 2035, registering a CAGR of 13.82% (2026–2035). The U.S. liquid biopsy market report provides detailed analysis of market size, growth trends, and forecast statistics, along...
January 06, 2026
According to market projections, the global novel spectrometry market, valued at USD 4.18 billion in 2025, is anticipated to reach USD 23.35 billion by 2035, growing at a CAGR of 18.77% over the next decade. Advancements in technology and growing research and development activities drive the market. North America dominated the global market due to ...
January 05, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&D for new treatments and diagnoses....
January 05, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, val...
January 02, 2026
Market insights predict, the U.S. Tuberculosis (TB) Diagnostics Market was valued at USD 650.8 million in 2025 and is projected to reach USD 687.51 million in 2026, further expanding to USD 1,126.5 million by 2035 at a CAGR of 5.64% (2026–2035). This report provides in-depth coverage of market size, growth trends, test type, disease type...
January 02, 2026
Market insights predict the global magnetic resonance imaging (MRI) industry will increase from USD 7.54 billion in 2025 to USD 14.18 billion by 2035, achieving a CAGR of 6.52%. It is anticipated that rising disease prevalence will have a significant impact on market expansion....
December 30, 2025
According to market projections, the global lateral flow assays market, valued at USD 12.76 billion in 2025, is anticipated to reach USD 27.40 billion by 2035, growing at a CAGR of 7.94% over the next decade. The lateral flow assays market is expanding due to growing demand for point-of-care testing as well as growing development of multiplex and...
December 26, 2025
Projections indicate that, point-of-care infectious disease testing industry is projected to rise from USD 11.9 billion in 2024 to USD 17.75 billion by 2034, reflecting a CAGR of 4.34% over the next decade. The point-of-care infectious disease testing market is expanding due to patient-centric care as well as increasing lateral flow test innovation...
December 26, 2025
According to forecasts, the global endocrine testing market will grow from USD 2.99 billion in 2024 to USD 6.75 billion by 2034, with an expected CAGR of 8.54%. With more individuals proactively monitoring their health, the endocrine testing market is seeing a growing interest in personalized medicine and home-based testing kits. North America led ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com